Enzymatic pathways that regulate endocannabinoid signaling in the nervous system

被引:428
作者
Ahn, Kay [1 ]
McKinney, Michele K. [2 ,3 ]
Cravatt, Benjamin F. [2 ,3 ]
机构
[1] Pfizer Global & Dev, Groton, CT 06340 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA
关键词
D O I
10.1021/cr0782067
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The current state of the four major pathways for endocannabinoid metabolism that includes anandamide degradation, anandamide biosynthesis, 2-AG degradation, and 2-AG biosynthesis have been reviewed. Some of these pathways are relatively well characterized in terms of participating enzymes and the advent of specific research tools to probe their function in vivo. For other pathways, enzymes have been identified, but the specific roles that these proteins play remain to be clarified. Although these metabolic pathways present a unique set of experimental opportunities and challenges, common themes can also be selected from a global review of research into their composition and regulation. These themes include strong correlation between the extent of understanding of a specific metabolic pathway and the quality of genetic and pharmacological tools available to probe its functions; molecular events that occur between endocannabinoid production and degradation; and the discrimination of specific physiological functions for anandamide and 2-AG.
引用
收藏
页码:1687 / 1707
页数:21
相关论文
共 190 条
[51]   Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597):: Effects on anandamide and oleoylethanolamide deactivation [J].
Fegley, D ;
Gaetani, S ;
Duranti, A ;
Tontini, A ;
Mor, M ;
Tarzia, G ;
Piomelli, D .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01) :352-358
[52]   The cannabinoid system and its pharmacological manipulation - a review, with emphasis upon the uptake and hydrolysis of anandamide [J].
Fowler, Christopher J. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2006, 20 (06) :549-562
[53]   Molecular characterization of human and mouse fatty acid amide hydrolases [J].
Giang, DK ;
Cravatt, BF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2238-2242
[54]   Evidence against the presence of an anandamide transporter [J].
Glaser, ST ;
Abumrad, NA ;
Fatade, F ;
Kaczocha, M ;
Studholme, KM ;
Deutsch, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4269-4274
[55]   Anandamide transport: A critical review [J].
Glaser, ST ;
Kaczocha, M ;
Deutsch, DG .
LIFE SCIENCES, 2005, 77 (14) :1584-1604
[56]   Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis [J].
Gobbi, G ;
Bambico, FR ;
Mangieri, R ;
Bortolato, M ;
Campolongo, P ;
Solinas, M ;
Cassano, T ;
Morgese, MG ;
Debonnel, G ;
Duranti, A ;
Tontini, A ;
Tarzia, G ;
Mor, M ;
Trezza, V ;
Goldberg, SR ;
Cuomo, V ;
Piomelli, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) :18620-18625
[57]  
Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045
[58]   Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand [J].
Goparaju, SK ;
Ueda, N ;
Yamaguchi, H ;
Yamamoto, S .
FEBS LETTERS, 1998, 422 (01) :69-73
[59]   Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors [J].
Goparaju, SK ;
Ueda, N ;
Taniguchi, K ;
Yamamoto, S .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (04) :417-423
[60]   Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala [J].
Gulyas, AI ;
Cravatt, BF ;
Bracey, MH ;
Dinh, TP ;
Piomelli, D ;
Boscia, F ;
Freund, TF .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 20 (02) :441-458